Transcript Statistical Leaders EFSPI Presentation June 2011 FA

EFSPI Statistical Leaders Meeting
8th June 2011
1
Welcome
• 2nd European Statistical Leaders Meeting
• Thank you to organising team
–
–
–
–
–
Chrissie
Stephen
Maylis
Lesley
Ian
• Thank you Amgen
– for Hosting the Meeting
• Introductions
2
Agenda
Time
9:00- 9:15
9:15-10:45
Topic
Presenter/Facilitator
EFPSI President Welcome Address
Organisers welcome
Model Based Drug Development
Francois Aubin
Lesley France
Stephen Pyke / Ian Hirsch
10:45-11:00
Break
11:10-12:30
Comparative Drug Effects – Network Meta-analyses
12:30-13:30
Lunch break
13:30-13:45
Maylis Coste / Chrissie
Fletcher
Update from last Meeting
• HTA Update
• Risk Benefit
13:45 – 14:15 Accreditation of Pharmaceutical Statisticians
Chrissie Fletcher / Lesley
France
14:15 – 14:30 Update from last Meeting
Professional Development for Statisticians
14:30 – 14:45 Break
14:45 – 16:15 Totality of Evidence – Can we make better use of
Resources
16:15
Meeting summary and Actions
Hans Uli Burger
Egbert Biesheuvel
Ian Hirsch / Lesley France
3
16:30
Meeting Close
What is EFSPI?
• EFSPI = European Federation of Statisticians in
the Pharmaceutical Industry
• Founded in 1992
• EFSPI is an “umbrella”, non-profit making
organisation
• A federation of National European Groups
• Now have 10 national groups
• No individual members
• Our national organisations collectively represent
2800 members
4
EFSPI - Our members
SFdS
BIAS
SSL
PSI
APF
SBS/BVS
DSBS
PSDM
BBS
FMS
5
EFSPI Objectives
• To promote professional standards of statistics
and the standing of the statistical profession in
the pharmaceutical industry
• To offer a collective expert input on statistical
matters to national and international authorities
and organisations
• To exchange information on and harmonise
attitudes to the practise of statistics in the
European Pharma Industry and within member
groups
6
EFSPI website
www.efspi.org
Statistical Leaders Meeting
• Develop a forum for Statistical Leaders to
– Network and share ideas
– Shape and influence our environment
• Education & Continuing Professional Development
• Methodology Development & Identification of Best
Practice
• Regulatory and Industry policies
• Effective working with differing resourcing models
– Help to shape the strategy for EFSPI
8
Objectives of this meeting
• To identify up to 3 priority actions for the
strategic direction of EFSPI in
– Professional Development for Statisticians
– Model Based Drug Development
– Comparative Drug Effects – Network Meta-analyses.
– Utilising the Totality of Evidence
• Provide feedback from our last meeting
• Identify experts who would like to be engaged in
European initiatives
9
Format of the meeting
• Each topic will be introduced by a presenter
• Facilitated discussion to identify 3 priority actions
• Facilitators will summarise key actions at the
end of each discussion
10
End of meeting
11
Summary and Close
• Review priorities from each session
• Identify experts
• Take the recommendations to the next council
meeting
• Feedback to participants of this meeting in
Autumn
12